Phase II study of lapatinib in combination with ErbB2-amplified recurrent or metastatic breast cancer (Turkish Oncology Group Trial) (Abstract No: e13079) J Clin Oncol 29 (suppl)


KARACA H.

Annual Meeting of American Society of Clinical Oncology, United States Of America, 1 - 04 January 2011, pp.1

  • Publication Type: Conference Paper / Full Text
  • Country: United States Of America
  • Page Numbers: pp.1
  • Erciyes University Affiliated: Yes